Do You Need to Stop Ozempic or Wegovy Before Eye Injections or Retina Surgery?
Ozempic, Wegovy, and Eye Procedures at a Glance
In most cases, no. And it is not a call to make on your own. A routine eye injection in the office does not use sedation. That means the stomach worry behind this whole question does not apply to it. Retina surgery in an operating room is different, because sedation or a full anesthetic may be used.
Five medical societies now advise a plan made for each person by you, the doctor who prescribes the drug, the doctor doing the procedure, and the anesthesia team, rather than one blanket stop rule1. So tell each of them that you take it. Then let them agree the plan.
Do not skip a dose on your own. Your blood sugar can rise. And the reason for holding a dose may not apply to your procedure at all.
The worry that drives this question is about the stomach, not the eye. These drugs slow how fast food leaves the stomach, and an anesthetic that blunts your reflexes can turn a full stomach into an inhalation risk. That chain only matters when you are sedated or put to sleep. Nearly all eye injections are given with local anesthesia, most often numbing drops2, so you stay awake, keep your reflexes, and do not fast. Retina surgery is done under a range of anesthesia options, from numbing drops or a block around the eye through to general anesthesia3. Sedation and general anesthesia are the settings where the question earns its keep.
Stopping a diabetes or weight medicine without telling the prescriber creates a second problem while solving a first. Blood sugar can climb, and a missed weekly injection is not a neutral event. The safer move is a call to the clinic booking your procedure and a message to whoever prescribes the drug, ideally a couple of weeks ahead. If your procedure is being arranged urgently, say what you take and let the team work around it.
What Ozempic and Wegovy Are and Why the Question Comes Up
Ozempic and Wegovy both contain semaglutide, a drug in the group known as GLP-1 receptor agonists, given as a weekly injection under the skin. Ozempic is labeled for type 2 diabetes4, while Wegovy is labeled for reducing excess body weight and keeping it down alongside a reduced-calorie diet and more activity, and for lowering the risk of major heart events5. Same molecule, different dosing and different purpose, and for the questions on this page they behave the same way.
Concern grew because these drugs slow stomach emptying, and sedation blunts the reflexes that normally protect the airway. Measured slowing of solid-food stomach emptying has averaged about 36 minutes, and how much that matters in practice is still unclear6. That uncertainty is why the advice has shifted more than once.
How These Medicines Are Taken and What Holding a Dose Means
Semaglutide is taken once a week, and both brands start low and step up over months to reduce stomach upset. That build-up phase matters here. People still climbing to their target dose, or recently increased, tend to have more nausea and slower stomach emptying than people who have been steady on the same dose for a long time. Where you sit on that curve is one of the first things a pre-procedure team will ask about.
The 2023 anesthesiology consensus advised withholding daily forms on the day of a procedure and weekly forms for a week beforehand, no matter the drug's purpose or the type of procedure, while the later joint guidance moved to case-by-case assessment in which people who are not building their dose, not on high weekly doses, free of stomach symptoms, and free of conditions that slow stomach emptying may continue the drug6. Where concern remains, the joint guidance suggests measures such as a day of clear liquids rather than an automatic stop1.
Four people share this decision, and none of them is the internet. The prescriber knows what a missed dose does to your control, the retina specialist knows whether your procedure involves sedation at all, the anesthesia team knows the airway risk, and you know your symptoms and your last dose. Bring the drug name, the dose, and the date of your last injection to the pre-procedure conversation.
Eye Injections in the Office: What Usually Happens
An injection of an anti-VEGF drug into the eye is a short outpatient procedure. It is given with local anesthesia, usually numbing drops, with an antiseptic preparation and a small lid holder2. You are awake throughout, you eat normally beforehand, and nothing about the appointment depends on your stomach. On its own, that appointment is not a reason to hold a weekly injection, though your own clinic may still have a policy it wants to follow.
Even when nothing changes, the drug belongs on your list, because it shapes the eye picture rather than the injection. There is a useful parallel here. The theoretical increased risk of bleeding inside the eye in people on long-term blood thinners who receive an eye injection has not been substantiated in studies2. Whether to change a blood thinner is still a decision for the team that prescribed it. The wider lesson runs through this page: a theoretical risk deserves testing rather than an automatic stop, because stopping a medicine has its own cost.
Retina Surgery in an Operating Room: A Different Conversation
Vitrectomy, the operation used for bleeding, membranes, and retinal detachment, is done in an operating room rather than a clinic room. One option is monitored anesthesia care, meaning sedation plus a numbing block around the eye rather than being put fully to sleep. In one small prospective comparison of 40 patients divided between monitored anesthesia care and general anesthesia, vitrectomy under moderate sedation was completed without switching to general anesthesia in all 20 of the sedation group3. That is one small study rather than a description of what every center does, so ask yours. Some people still need general anesthesia, including those who cannot lie still or tolerate sedation, and that is the group for whom the stomach question matters most.
They are balancing two risks that pull in opposite directions. On one side sits the chance of stomach contents reaching the lungs under sedation. On the other sits the harm of interrupting a medicine that is holding your blood sugar or weight steady, and the delay if surgery is postponed for a retinal problem that will not wait. Recent guidance is explicit that this balance is judged for the individual, not applied as a rule to everyone1.
Ask three things and you will have covered most of it: will I be sedated or asleep for this, do you want me to change anything about my weekly injection, and what should I eat or drink and when. Write down the answers with a date attached, and ask who to call if your readings run high while a dose is held.
Side Effects of Semaglutide That Matter for Your Eyes
This is the eye effect with the strongest paper trail, and it is not really about the drug so much as about speed. The Ozempic label reports that in a two-year trial of people with type 2 diabetes at high heart risk, diabetic retinopathy complications occurred in about 30 of every 1,000 people on semaglutide against about 18 of every 1,000 on placebo, with the difference concentrated among people who already had retinopathy (about 82 of every 1,000 against about 52 of every 1,000) rather than those who did not (about 7 of every 1,000 against about 4 of every 1,000), and it notes that rapid improvement in glucose control has been associated with temporary worsening of diabetic retinopathy and that people with a history of retinopathy should be monitored4.
Read those numbers as a reason for eye monitoring, not a reason for panic or for quitting. The effect described is a temporary worsening while sugars fall quickly, and it lands mainly on eyes that already have disease. The Wegovy label carries the same warning and reports diabetic retinopathy in about 40 of every 1,000 treated patients against about 27 of every 1,000 on placebo5. The practical response is a dilated eye exam before or soon after starting, and a schedule of checks agreed with your eye doctor while your control improves.
NAION is a sudden, usually painless loss of vision in one eye caused by a circulation problem at the optic nerve head. European regulators concluded that it is a very rare side effect of semaglutide, affecting up to 1 in 10,000 people, working out at roughly one extra case per 10,000 person-years of treatment, and advised that anyone with sudden loss of vision or rapidly worsening eyesight during treatment should contact their doctor without delay7. Very rare is the operative phrase, and knowing the warning sign is what turns it into useful information rather than dread.
Nausea, vomiting, bloating, feeling full very early in a meal, or constipation are the symptoms that move you from the reassuring group into the cautious one. Those symptoms, along with dose escalation, high weekly doses, and conditions that slow stomach emptying, are what tip a team toward withholding a dose or extending the fast6. Report them honestly before a procedure even if they feel minor, because they change what the anesthesia team plans rather than whether they will look after you.
Who Should Not Simply Continue as Usual
Some people are genuinely in a higher-risk group and should expect a different plan. That includes anyone on a rising dose, anyone with ongoing nausea or vomiting, anyone with gastroparesis or another condition that slows the stomach, and anyone booked for a procedure under general anesthesia rather than local anesthesia. Guidance names exactly these features as the ones that justify withholding a dose or adding precautions6. None of this means the procedure cannot go ahead. It means the preparation differs.
Pausing has costs of its own, especially where the drug is doing a job nothing else is doing. Poorly controlled diabetes, a recent history of very high readings, an urgent retinal problem that should not be delayed, and the simple fact that an office injection involves no sedation all point away from stopping. Eye organizations have taken a similar line about NAION, advising against blanket discontinuation of semaglutide because stopping can carry significant risks to overall health8. The theme repeats: no automatic answer in either direction.
Risks, Trade-Offs, and a Realistic Outlook
Put the two sides next to each other honestly. Inhaling stomach contents under anesthesia is serious but uncommon, and largely preventable through the fasting rules and airway technique your anesthesia team already uses. Losing control of blood sugar, or postponing surgery for a detaching retina, is neither rare nor harmless. That is why the guidance stopped issuing a single rule.
Studies of semaglutide and NAION have gone both ways, with some finding a raised risk and others no statistically significant increase, which is why professional bodies favor an informed conversation over a rule8. One single-center record review recorded NAION in 17 of 194 people with diabetes prescribed semaglutide against 6 of 516 on other diabetes medicines, in a specialist clinic population that limits how far the finding stretches9. The label itself notes that the long-term effect of glucose control with semaglutide on retinopathy has not been studied4. Expect this advice to keep moving.
When to Call Your Doctor About Your Eyes or Your Medicine
Most people on these drugs never have an eye problem from them. A few symptoms should still send you to an eye doctor the same day rather than to your next scheduled visit, because the conditions behind them are treatable when they are caught early.
- A sudden drop in vision in one eye, with or without pain
- A dark curtain or shadow spreading across your vision
- A sudden shower of new floaters or flashing lights
- A new blind patch in the middle or to one side of your sight
- Severe eye pain with redness or nausea
Regulators advise that anyone with sudden loss of vision or rapidly worsening eyesight while on semaglutide should contact their doctor without delay, and that the drug should be stopped if the optic nerve condition is confirmed7. Confirming it takes an examination, not a guess, which is exactly why the call is worth making early.
Call the clinic ahead of the day if you develop nausea or vomiting, if you cannot keep food down, if your dose was raised in the past few weeks, or if you missed the injection you were told to take. Any of these can change the fasting instructions or the anesthesia plan. Finding out on arrival wastes your morning and sometimes costs you the appointment slot.
If you have diabetes, the standard advice is a dilated eye exam on the schedule your eye doctor sets, and that becomes more useful, not less, when glucose control is improving quickly. The labels for both brands direct that people with a history of diabetic retinopathy be monitored45. Ask for an exam around the time you start or step up the dose, so any change has a baseline to be measured against.
Questions People Ask About Ozempic, Wegovy, and Eye Procedures
Usually not, because an in-office eye injection uses numbing drops rather than sedation, and fasting rules exist to protect an airway that anesthesia has relaxed. You stay awake and keep your normal reflexes throughout. Your clinic still sets its own instructions, so follow whatever they send you and mention the drug when you book. If your appointment involves sedation for any reason, the fasting question becomes live and the team will tell you what to do.
Some teams still follow the older approach of holding a weekly injection for a week before a procedure, and some follow the newer individualized approach. Both are defensible, and the difference reflects genuinely unsettled evidence rather than one team being wrong. Ask what your center does and why, and make sure the doctor who prescribes the drug knows the plan so your blood sugar cover is arranged too.
Tell the team on arrival rather than staying quiet about it. Surgery is not automatically canceled. Anesthesia teams have options, including treating you as though your stomach is full, using an ultrasound scan of the stomach to look for contents, or adjusting the anesthetic technique. Silence is the only choice that removes those options, so say when your last injection was, even if you think it will cause a delay.
The label describes more diabetic retinopathy complications on semaglutide than on placebo in a two-year trial, concentrated among people who already had retinopathy, and links temporary worsening to rapid improvement in glucose control rather than to the drug alone4. That is a monitoring issue, not a reason to abandon treatment that protects your heart, kidneys, and nerves. Tell your eye doctor you have started or increased the dose, and agree on a check-up schedule.
Eye organizations have specifically advised against stopping across the board, because the risk is very rare while the health consequences of stopping are not. The reasonable path is an informed conversation with the prescriber, particularly if you have had an optic nerve problem before. If sudden vision loss happens while you are on the drug, that is a different situation and needs same-day assessment.
The perioperative guidance covers this drug class rather than one brand1, so other drugs in the family, such as dulaglutide and liraglutide, and the related drug tirzepatide, all belong on your pre-procedure medication list. What varies is the dosing interval and how far along you are in building the dose, which is why teams ask for the exact drug, dose, and date rather than just the class.
More Questions About Timing, Blood Sugar, and Your Eye Care
As soon as your procedure is booked, and ideally at least two weeks before the date. That leaves room for the prescriber and the procedure team to agree a plan, for blood sugar cover to be arranged if a dose is held, and for you to avoid a last-minute cancellation. If surgery is being scheduled urgently, say what you take at the first appointment.
Ask the prescriber that question directly, because the answer depends on what else you take. In general, holding a glucose-lowering medicine tends to push readings up rather than down, so agree on how often to test, what reading should prompt a call, and whether anything else in your regimen changes in the meantime. Bring your readings to the pre-procedure visit rather than describing them from memory.
If you have diabetes, a current dilated eye exam is worth having whether or not you are starting these medicines, and it is especially useful as a baseline when glucose control is about to improve quickly. The labels direct monitoring for people with a history of diabetic retinopathy. If you have no diabetes and are taking the drug for weight, routine eye screening for this reason alone is not established, so raise it with your prescriber.
- Will my eye procedure involve sedation or general anesthesia, or only numbing drops
- Do you want me to hold my weekly injection, and if so, for how long
- What should I eat and drink, and from what time, on the day before
- Who is arranging my blood sugar cover if a dose is held
- Do I have diabetic retinopathy now, and how often should my eyes be checked
- What symptoms should make me call you the same day
- Clinical Gastroenterology and Hepatology; joint guidance of the American Gastroenterological Association, American Society for Metabolic and Bariatric Surgery, American Society of Anesthesiologists, International Society of Perioperative Care of Patients with Obesity, and Society of American Gastrointestinal and Endoscopic Surgeons (2024). Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period.
- American Academy of Ophthalmology, EyeNet Magazine (2023). How to Give Intravitreal Injections.
- Peer-reviewed prospective clinical comparison (PMC12499363) (2025). Conscious Monitored Anesthesia Care versus General Anesthesia for Vitreoretinal Surgeries.
- DailyMed, U.S. National Library of Medicine (U.S. product labeling, Novo Nordisk) (2025). OZEMPIC (semaglutide) injection, solution: full prescribing information.
- DailyMed, U.S. National Library of Medicine (U.S. product labeling, Novo Nordisk) (2025). WEGOVY (semaglutide) injection, solution: full prescribing information.
- Cleveland Clinic Journal of Medicine, peer-reviewed review (2025). Should glucagon-like peptide 1 receptor agonists be withheld during the preoperative period?.
- European Medicines Agency, Pharmacovigilance Risk Assessment Committee (regulatory product-information decision) (2025). PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy.
- American Academy of Ophthalmology, EyeNet Magazine (2025). Semaglutide Use and the Risk of NAION: Current Thinking.
- JAMA Ophthalmology, single-centre retrospective matched cohort (Mass Eye and Ear) (2024). Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide.